A C2-symmetrical bis-thiourea chiral solvating agent
(CSA),
TFTDA
, for NMR spectroscopy has been obtained
by reacting
(1
R
,2
R
)-1,2-bis(2-hydroxyphenyl)ethylenediamine
and 3,5-bis(trifluoromethyl)phenyl isothiocyanate.
TFTDA
shows remarkable propensity to enantiodiscriminate
N
-trifluoroacetyl (
N
-TFA) and
N
-acetyl
(
N
-Ac) derivatives of amino acids with free carboxyl
functions, with the co-presence of 1,4-diazabicyclo[2.2.2]octane (DABCO)
as the third achiral additive, which is needed for substrate solubilization.
TFTDA
shows enhanced enantiodiscriminating efficiency in comparison
with the corresponding monomeric counterpart,
TFTMA
,
pointing out cooperativity between its two symmetrical entities. A
wide range of amino acid derivatives have been efficiently enantiodiscriminated
in CDCl
3
, with high enantioresolution quotients, which
guarantee high quality in applications devoted to the quantification
of enantiomers. High enantiodiscriminating efficiency is maintained
also in diluted 5 mM conditions or in the presence of sub-stoichiometric
amounts of CSA (0.3 equiv). The role of phenolic hydroxyls in the
DABCO-mediated interaction mechanism between
TFTDA
and
the two enantiomeric substrates has been pointed out by means of diffusion-ordered
spectroscopy (DOSY) and rotating frame Overhauser effect spectroscopy
(ROESY) experiments. A conformational model for both the CSA and its
diastereomeric solvates formed with the two enantiomers of
N
-acetyl leucine has also been conceived on the basis of
ROE data in order to give a chiral discrimination rationale.